ascendis pharma glp-1 receptor agonist Novo inks deal to develop long-acting GLP-1, other metabolic drugs Mapping the effectiveness and risks

Parkinsonism Relat Disord 46(Suppl 1):S19-s23

It works by using phages to specifically target and eliminate pathogenic bacteria while leaving beneficial gut microbes intact, potentially restoring microbial balance and reducing inflammation

GHK-Cu builds new infrastructure

3.8 Shared molecular drivers of ferroptosis in CNS injuries Ferroptosis is a major pathogenic process in CNS injuries, such as stroke, TBI, and neurodegenerative disorders

7 20 This action prevents the acne-causing bacteria, Acne bacillus, from taking hold and reduces the number of acne-causing bacteria better than antibiotics

The trial concluded that AOD-9604 did not induce significant weight loss, leading to a halt in the development of the drug as a weight-loss solution